Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy is a condition characterized by the non-cancerous enlargement of the prostate gland, leading to a blockage in the urethra. This condition can cause several complications, including difficulties in urine retention, bladder stones, incontinence due to overfilling, increased sensitivity of the bladder, and urinary tract infections. There are various treatment options available for BPH, including prescription drugs, active observation or surveillance, mono drug and combined therapies, phytotherapies, as well as minimally invasive (MI) and invasive surgeries. Devices such as resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants are commonly used during these surgeries.
According to a report by TechSci Research, the Global Benign Prostate Hyperplasia (BPH) Treatment Market is expected to register a significant CAGR between 2023 and 2028 due to the rising incidence of hormonal imbalance and aging population. BPH Treatment involves minimally invasive techniques that help alleviate symptoms caused by the prostate pressing against the urethra, leading to urine retention. Although BPH is benign and non-cancerous, a man’s risk of developing it increases with age and family history. However, the market growth may be hindered in the future due to the strict regulatory scenario and lack of awareness regarding urological diseases. Additionally, the shortage of skilled medical professionals to perform minimally invasive BPH surgeries in emerging countries could further slow down the market growth.
The Global BPH Treatment Market can be segmented into drug treatment, surgical treatment, end-user, region, and company. The drug treatment segment can be divided into alpha-blockers, 5-alpha reductase inhibitors, and phosphodiesterase-5 inhibitors, with the latter expected to exhibit significant growth during the forecast period due to their efficacy. Based on the surgical treatment, the market can be classified into various procedures, with the transurethral resection of the prostate (TURP) segment expected to dominate the market through 2028 due to the increasing demand for minimally invasive procedures and government health insurance policies. The hospital & clinics segment is likely to remain dominant in the forecast years and propel the growth of the Global BPH Treatment market due to the increase in healthcare facilities and government policies that promote treatments. Moreover, hospitals are more convenient than ambulatory surgical centers, which further drives the growth of the market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Global Benign Prostate Hyperplasia (BPH) Treatment Market” – https://www.techsciresearch.com/report/benign-prostate-hyperplasia-bph-treatment-market/14694.html
The leading companies operating in the Global BPH Treatment Market are:
- Boston Scientific Corporation
- Coloplast Corporation
- Teleflex Incorporated
- Olympus Corporation
- Glaxo Smith Kline PLC
- Eli Lily
- Abbott Laboratories
- Medifocus Inc.
- Urologix, LLC
- Pfizer Inc.
Customers can also request for 10% free customization on this report.
“The prevalence of the BPH is rising, which is encouraging the use of cutting-edge therapies including laser therapy, prostatic stenting, and UroLift therapy and propelling the growth of the sector in the area. The advancement of the players in the region over the coming few years will also be supported by attractive reimbursement rules and an increase in the number of qualified surgeons. There are a number of device and pharmaceutical businesses in the area, and they are all keenly interested in undertaking R&D operations and developing new products to improve the standard of care. Furthermore, laser therapy is widely used due to the availability of cutting-edge medical infrastructure. Modern laser equipment is available in many clinics and urology centres to treat BPH, which advances the area.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“BPH Treatment Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitors, and phosphodiesterase-5 inhibitors), By Surgical Treatment (Transurethral resection of the prostate (TURP), Prostatic Urethral Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Technique (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), and Others), By End User (Hospitals & Clinics, , Ambulatory Surgical Centers, and Others), By Region,” has evaluated the future growth potential of Global BPH Treatment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global BPH Treatment Market.
Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14694
Related Reports:
Australia tattoo removal market
Europe diagnostic imaging market
Australia microfluidics market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com